知镜 Cognispect · 医学文献与研究工作台

High dose IFN-α2b as post operative adjuvant therapy for acral melanoma: a multi-center real-world cohort study of 171 Chinese patients.

Yang K, Lan S, Wang Y, Wu J, Cai X, Jiang K, Guo Z, Xiang M, Zhou H, Li J, Liu F, Gui J, Mao Y, Meng H, Ji X, Pang J, Yang X, Feng L, Zhang W, Wu D.
Frontiers in oncology · 2026-08-17 · PMID 42676389

文献摘要

Background This study aimed to investigate recurrence patterns and survival outcomes in Chinese patients with AM who received postoperative adjuvant High-dose interferon (HD-IFN), and to assess how treatment duration and the interval between surgery and therapy initiation relate to recurrence and survival. Methods A multi-center, retrospective cohort study involving 171 patients with AM who received postoperative adjuvant HD-IFN therapy between January 2012 and March 2025 was conducted at five melanoma diagnostic and treatment centers across China. Results The median follow-up duration was 75.7 months. Median recurrence-free survival (RFS) and overall survival (OS) were 37.5 and 93.7 months, respectively. Stratified by recurrence risk, patients in the low-risk, high-risk, and very high-risk groups had median RFS of 64.1, 31.6, and 13.8 months ( P = 0.035), and median OS of 131.9, 82.1, and 61.9 months, respectively ( P = 0.027). Conclusion Results show that full-course HD-IFN treatment is statistically associated with improved survival in high-risk and very high-risk subgroups, whereas the timing of HD-IFN initiation within 3 months after surgery makes no significant difference to prognosis.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。